The global peptic ulcer drugs market size was valued at USD 4.1 billion in 2021, growing at a significant CAGR of 2.1% from 2022-28. Peptic ulcers are a collection of gastrointestinal illnesses that include gastritis, gastric ulcers, and duodenal ulcers, as well as gastroesophageal reflux disease (GERD) (GERD). Drugs that reduce gastric ulcer secretion, such as PPIs and H2 receptor...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian